Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine in Nocturnal Peritoneal Dialysis Solution
NCT00922701Phase 2Completed
- Sponsor
- Iperboreal Pharma
- Start
- Jun 2004
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in end stage renal disease (ESRD), sponsored by Iperboreal Pharma. Started Jun 2004; status: completed.
02
Drugs
levocarnitine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00922701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922701.